Study Shows Stents Coated with
Selected Abstract
Study Shows Stents Coated with AVI BioPharma's Antisense Compound Reduces Coronary Restenosis.
Business Editors & Health/Medical Writers PORTLAND, OreBUSINESS WIRENov. 14, 2001 The study also compared AVI's antisense coated stents to paclitaxel, dactinomycin, and sirolimus coated stents. AVI BioPharma, Inc. (Nasdaq:AVII)(Nasdaq:AVIIW)(Nasdaq:AVIIZ) demonstrated that stents coated with ... November 14, 2001; Business Wire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Study Shows Stents Coated with AVI BioPharma's Antisense Compound Reduces Coronary Restenosis.
|
